A Comparative, Randomized, Open-label, Multicenter Study, of Directly Observed Treatment of Chronic Hepatitis C (DOT) and auto administrated treatment with Copegus (Ro 20-9963) and Pegasys (Ro 25-8310).
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 01 Jun 2011 New trial record